PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-7.84%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.4B
AUM Growth
+$1.4B
(-8.8%)
Cap. Flow
+$76.5M
Cap. Flow
% of AUM
5.45%
Top 10 Holdings %
Top 10 Hldgs %
48.29%
Holding
242
New
48
Increased
30
Reduced
52
Closed
51
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$32.5M |
| 2 |
Aclaris Therapeutics
ACRS
|
$22.5M |
| 3 |
Galapagos
GLPG
|
$20.6M |
| 4 |
Amicus Therapeutics
FOLD
|
$15.8M |
| 5 |
ANI Pharmaceuticals
ANIP
|
$15.5M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$17.2M |
| 2 |
DexCom
DXCM
|
$15.7M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$13.5M |
| 4 |
Assertio
ASRT
|
$13.4M |
| 5 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$12.4M |
Sector Composition
| 1 | Healthcare | 94.07% |
| 2 | Consumer Discretionary | 0.07% |
| 3 | Industrials | 0.05% |
| 4 | Energy | 0.02% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Neurocrine Biosciences
NBIX
$13.8B
| $128M | 9.13% | 3,316,523 +840,251 | +34% | +$32.5M |
|
|
TSRO
2
DELISTED
TESARO, Inc.
TSRO
| $92.5M | 6.58% | 687,993 +5,578 | +0.8% | +$750K |
|
|
3
Amicus Therapeutics
FOLD
$2.34B
| $86M | 6.11% | 17,296,672 +3,180,028 | +23% | +$15.8M |
|
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $76M | 5.4% | 2,769,829 -625,407 | -18% | -$17.2M |
|
|
ARAV
5
DELISTED
Aravive, Inc. Common Stock
ARAV
| $61.9M | 4.4% | 4,153,685 +125,000 | +3% | +$1.86M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $50.9M | 3.62% | 2,687,412 +240,930 | +10% | +$4.56M |
|
|
NXTM
7
DELISTED
NxStage Medical Inc.
NXTM
| $50.5M | 3.59% | 1,927,989 +258,286 | +15% | +$6.77M |
|
8
Xencor
XNCR
$580M
| $47M | 3.34% | 1,785,018 +288,789 | +19% | +$7.6M |
|
|
GBT
9
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $45.2M | 3.22% | 3,128,978 +794,810 | +34% | +$11.5M |
|
|
EGRX
10
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $39.5M | 2.81% | 498,198 -46,572 | -9% | -$3.7M |
|
|
11
Aclaris Therapeutics
ACRS
$209M
| $34.2M | 2.43% | 1,260,847 +830,847 | +193% | +$22.5M |
|
12
Ardelyx
ARDX
$1.53B
| $26.1M | 1.85% | 1,836,196 +778,939 | +74% | +$11.1M |
|
13
Iovance Biotherapeutics
IOVA
$807M
| $24.8M | 1.76% | 3,567,553 | – | – |
|
14
Regenxbio
RGNX
$451M
| $23.8M | 1.69% | 1,282,286 | – | – |
|
|
CLCD
15
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $23.3M | 1.66% | 641,364 +89,334 | +16% | +$3.25M |
|
|
LJPC
16
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $23.1M | 1.64% | 1,319,274 -4,050 | -0.3% | -$71K |
|
|
AVXS
17
DELISTED
AveXis, Inc. Common Stock
AVXS
| $22.6M | 1.61% | 473,531 +283,531 | +149% | +$13.5M |
|
|
DBVT
18
DBV Technologies
DBVT
$264M
| $21.5M | 1.53% | 610,643 +47,375 | +8% | +$1.66M |
|
|
19
Galapagos
GLPG
$2.07B
| $20.6M | 1.47% | +304,531 | New | +$20.6M |
|
|
VBIV
20
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $20.4M | 1.45% | 6,565,843 +3,507,410 | +115% | +$10.9M |
|
21
Wave Life Sciences
WVE
$1.53B
| $18.1M | 1.29% | 665,198 -18,250 | -3% | -$496K |
|
|
22
ANI Pharmaceuticals
ANIP
$2.03B
| $16.2M | 1.15% | 267,100 +255,539 | +2,210% | +$15.5M |
|
|
XLRN
23
DELISTED
Acceleron Pharma Inc.
XLRN
| $15.8M | 1.13% | 619,987 +30,097 | +5% | +$768K |
|
|
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $14.7M | 1.04% | 1,322,994 -50,290 | -4% | -$558K |
|
|
AVDL
25
Avadel Pharmaceuticals
AVDL
$1.43B
| $14.4M | 1.03% | 1,388,240 +24,529 | +2% | +$255K |
|